Oligonucleotide Synthesis Market Size 2022 | Top Impacting Factors that are Leading the Global Industry Worldwide

According to the report published by Allied Market Research, The Global Oligonucleotide Synthesis Industry Size stood at USD 5.19 billion in 2020 and is projected to reach USD 26.09 billion by 2030, exhibiting a CAGR of 17.1% from 2021 to 2030.

Rise in government investments and R&D expenditure in pharmaceutical & biotechnology companies, increase in use of synthesized oligonucleotides in molecular diagnostics and clinical applications, and surge in demand for high end customized oligos and upgradation in purification drive the growth of the global oligonucleotide synthesis market. However, challenging delivery of oligonucleotide drugs to specific targets and complexities associated with therapeutic oligos hinder the market growth. On the contrary, rise in focus on personalized medicines and potential in the developing economies are expected to open lucrative opportunities for the market players in the coming years.

Request a Sample Copy of the Report: https://www.alliedmarketresearch.com/request-sample/8721

Key Players of Global oligonucleotide synthesis Market Report: -

• Alnylam Pharmaceuticals, Inc.
• Danaher Corporation
• Biogen Inc.
• Ionis Pharmaceuticals, Inc.
• Eurofins Scientific
• LGC Limited
• Kaneka Corporation
• Sarepta Therapeutics, Inc.
• Merck KGAA
• Thermo Fisher Scientific, Inc.

Global oligonucleotide synthesis Market Segmentation: -

BY PRODUCT

• Oligonucleotide-based drugs
• Synthesized oligonucleotides
• Reagents
• Equipment

BY APPLICATION

• Therapeutic applications
• Research applications
• Diagnostic applications

BY END USER

• Hospitals
• Pharmaceutical & biotechnology companies
• Diagnostic laboratories
• CROs and CMOs
• Academic research institutes

For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/8721

By Region Outlook

• North America
(U.S., Canada, Mexico)

• Europe
(Germany, France, UK, Italy, Spain, Rest of Europe)

• Asia-Pacific
(Japan, China, India, Rest of Asia-Pacific)

• LAMEA
(Brazil, Saudi Arabia, South Africa, Rest of LAMEA)

By region, the global oligonucleotide synthesis market across North America held the largest share in 2020, accounting for more than one-third of the market. This is due to rise in R&D in life sciences, surge in focus on improving the safety & quality of healthcare, increase in demand for high-quality research tools for data reproducibility, and surge in focus on developing personalized therapeutics. However, the market across Asia-Pacific is expected to register the highest CAGR of 18.8% during the forecast period, owing to expanding healthcare infrastructure, surge in government support and investment, and economic development in the region.

Key Findings of the Study

• Based on product, the oligonucleotide-based drugs held the largest share in the global market in 2020.
• On the basis of application, the therapeutic application held the largest market share in 2020, and is expected to remain dominant throughout the forecast period.
• By end user, the hospitals segment held the largest market share in 2020, and is expected to remain dominant throughout the forecast period.
• Based on region, North America is expected to experience growth at the highest rate, registering a CAGR of 16.00% during the forecast period.

Our Market Research Solution Provides You Answer to Below Mentioned Question:

• Which are the driving factors responsible for the growth of market?
• Which are the roadblock factors of this market?
• What are the new opportunities, by which market will grow in coming years?
• What are the trends of this market?
• Which are main factors responsible for new product launch?
• How will each segment grow over the forecast period and how much revenue will these segments account for in 2031?
• How big is the global & regional market in terms of revenue, sales and production?
• Which region is dominating the global market and what are the market shares of each region in the overall market in 2022?
• Which region has more opportunities?

Get Access To Full Report: https://www.alliedmarketresearch.com/oligonucleotide-synthesis-market-A08356

David Correa
5933 NE Win Sivers Drive
205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.